Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Lucintel | PRODUCT CODE: 1387183

Cover Image

PUBLISHER: Lucintel | PRODUCT CODE: 1387183

Cardiac Ablation Market Report: Trends, Forecast and Competitive Analysis to 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4850
PDF (2 Users License)
USD 5800
PDF (5 Users License)
USD 6700
PDF (Corporate License)
USD 8850

Add to Cart

Cardiac Ablation Trends and Forecast

The future of the global cardiac ablation market looks promising with opportunities in the surgical center, cardiac center, and hospital markets. The global cardiac ablation market is expected to reach an estimated $8.9 billion by 2030 with a CAGR of 13.0% from 2024 to 2030. The major drivers for this market are large population base of cardiovascular patients, increasing awareness about better healthcare services with improving healthcare infrastructure, and growing adoption of sedendary lifestyle.

A more than 150-page report is developed to help in your business decisions.

Cardiac Ablation by Segment

The study includes a forecast for the global cardiac ablation by product, approach, end use, and region.

Cardiac Ablation Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Radiofrequency
  • Ablators
  • Electrical Ablators
  • Cryoablation Devices
  • Ultrasound Ablators

Cardiac Ablation Market by Approach [Shipment Analysis by Value from 2018 to 2030]:

  • Catheter-Based
  • Open/Surgical

Cardiac Ablation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Surgical Centers
  • Cardiac Centers
  • Hospitals
  • Others

Cardiac Ablation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cardiac Ablation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cardiac ablation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cardiac ablation companies profiled in this report include-

  • Icon Laboratories
  • Advanced Cardiac Therapeutics
  • Angiodynamics
  • Atricure
  • Biosense Webster
  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic
  • Olympus Corporation

Cardiac Ablation Market Insights

Lucintel forecasts that electrical ablators is expected to witness highest growth over the forecast period due to growing adoption of advanced therapeutic procedures to treat chronic cardiac disease.

Within this market, cardiac centers will remain the largest segment due to rising deployment across developing economies for effective treatment solutions.

APAC is expected to witness highest growth over the forecast period due to surge in geriatric population, rising prevalence of cardiovascular diseases, and growing healthcare sector in the region.

Features of the Global Cardiac Ablation Market

Market Size Estimates: Cardiac ablation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cardiac ablation market size by product, approach, end use, and region in terms of value ($B).

Regional Analysis: Cardiac ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, approachs, end uses, and regions for the cardiac ablation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cardiac ablation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the cardiac ablation market size?

Answer: The global cardiac ablation market is expected to reach an estimated $8.9 billion by 2030.

Q2. What is the growth forecast for cardiac ablation market?

Answer: The global cardiac ablation market is expected to grow with a CAGR of 13.0% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the cardiac ablation market?

Answer: The major drivers for this market are large population base of cardiovascular patients, increasing awareness about better healthcare services with improving healthcare infrastructure, and growing adoption of sedendary lifestyle.

Q4. What are the major segments for cardiac ablation market?

Answer: The future of the cardiac ablation market looks promising with opportunities in the surgical center, cardiac center, and hospital markets.

Q5. Who are the key cardiac ablation market companies?

Answer: Some of the key cardiac ablation companies are as follows:

  • Icon Laboratories
  • Advanced Cardiac Therapeutics
  • Angiodynamics
  • Atricure
  • Biosense Webster
  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic
  • Olympus Corporation

Q6. Which cardiac ablation market segment will be the largest in future?

Answer: Lucintel forecasts that electrical ablators is expected to witness highest growth over the forecast period due to growing adoption of advanced therapeutic procedures to treat chronic cardiac disease.

Q7. In cardiac ablation market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to surge in geriatric population, rising prevalence of cardiovascular diseases, and growing healthcare sector in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cardiac ablation market by product (radiofrequency, ablators, electrical ablators, cryoablation devices, and ultrasound ablators), approach (catheter-based and open/surgical), end use (surgical centers, cardiac centers, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cardiac Ablation Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cardiac Ablation Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cardiac Ablation Market by Product
    • 3.3.1: Radiofrequency
    • 3.3.2: Ablators
    • 3.3.3: Electrical Ablators
    • 3.3.4: Cryoablation Devices
    • 3.3.5: Ultrasound Ablators
  • 3.4: Global Cardiac Ablation Market by Approach
    • 3.4.1: Catheter-Based
    • 3.4.2: Open/Surgical
  • 3.5: Global Cardiac Ablation Market by End Use
    • 3.5.1: Surgical Centers
    • 3.5.2: Cardiac Centers
    • 3.5.3: Hospitals
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cardiac Ablation Market by Region
  • 4.2: North American Cardiac Ablation Market
    • 4.2.2: North American Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
  • 4.3: European Cardiac Ablation Market
    • 4.3.1: European Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
    • 4.3.2: European Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
  • 4.4: APAC Cardiac Ablation Market
    • 4.4.1: APAC Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
    • 4.4.2: APAC Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
  • 4.5: ROW Cardiac Ablation Market
    • 4.5.1: ROW Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
    • 4.5.2: ROW Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cardiac Ablation Market by Product
    • 6.1.2: Growth Opportunities for the Global Cardiac Ablation Market by Approach
    • 6.1.3: Growth Opportunities for the Global Cardiac Ablation Market by End Use
    • 6.1.4: Growth Opportunities for the Global Cardiac Ablation Market by Region
  • 6.2: Emerging Trends in the Global Cardiac Ablation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cardiac Ablation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiac Ablation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: lcon Laboratories
  • 7.2: Advanced Cardiac Therapeutics
  • 7.3: Angiodynamics
  • 7.4: Atricure
  • 7.5: Biosense Webster
  • 7.6: Boston Scientific Corporation
  • 7.7: Conmed Corporation
  • 7.8: Medtronic
  • 7.9: Olympus Corporation
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!